Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 15625368

Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2005 Jan 1
First author
McDermott DF

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2005 Apr 20;23(12):2877
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2005 Sep 1;23(25):6267-8; author reply 6268-9. doi: 10.1200/JCO.2005.01.5099.
    note
    Source null
    related pmid
    16135500
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2005 Sep 20;23(27):6797-8; author reply 6798-9. doi: 10.1200/JCO.2005.02.1709.
    note
    Source null
    related pmid
    16170190
    relationship
    Comment in

Authors and identifiers

  1. name
    McDermott DF
    type
    Author
  2. name
    Regan MM
    type
    Author
  3. name
    Clark JI
    type
    Author
  4. name
    Flaherty LE
    type
    Author
  5. name
    Weiss GR
    type
    Author
  6. name
    Logan TF
    type
    Author
  7. name
    Kirkwood JM
    type
    Author
  8. name
    Gordon MS
    type
    Author
  9. name
    Sosman JA
    type
    Author
  10. name
    Ernstoff MS
    type
    Author
  11. name
    Tretter CP
    type
    Author
  12. name
    Urba WJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    McDermott DF
    type
    Author
  2. name
    Regan MM
    type
    Author
  3. name
    Clark JI
    type
    Author
  4. name
    Flaherty LE
    type
    Author
  5. name
    Weiss GR
    type
    Author
  6. name
    Logan TF
    type
    Author
  7. name
    Kirkwood JM
    type
    Author
  8. name
    Gordon MS
    type
    Author
  9. name
    Sosman JA
    type
    Author
  10. name
    Ernstoff MS
    type
    Author
  11. name
    Tretter CP
    type
    Author
  12. name
    Urba WJ
    type
    Author
bibliography ids
  1. nci-bib-727be3301591a2bfcef080ab
book metadata
content sha256
8bc4b2ee9b203859bf1b530d319ac4917cbdf6417aae95f472dd18c104846c3c
document type
citation
dois
  1. 10.1200/JCO.2005.03.206
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:15625368
immutable id
pubmed:15625368@8bc4b2ee9b203859bf1b530d319ac4917cbdf6417aae95f472dd18c104846c3c
journal
abbreviation
J Clin Oncol
issn electronic
Source null
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
133-41
volume
23
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2005 Apr 20;23(12):2877
    note
    Source null
    related pmid
    Source null
    relationship
    Erratum in
    url
    Source null
  2. citation
    J Clin Oncol. 2005 Sep 1;23(25):6267-8; author reply 6268-9. doi: 10.1200/JCO.2005.01.5099.
    note
    Source null
    related pmid
    16135500
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2005 Sep 20;23(27):6797-8; author reply 6798-9. doi: 10.1200/JCO.2005.02.1709.
    note
    Source null
    related pmid
    16170190
    relationship
    Comment in
outcomes validated
false
pmid
15625368
provenance
batch id
97b9e848a139d5f8d462
provider
NCBI PubMed ESummary
record sha256
32e23813c0b164b1a76e40872cc90e0db3db8e6dd2af5f486fe4f32bf270f1f1
response sha256
a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
retrieved at
2026-09-09T23:45:57.930512+00:00
publication date
display
2005 Jan 1
precision
day
year
2005
publication types
  1. Clinical Trial
  2. Clinical Trial, Phase III
  3. Comparative Study
  4. Journal Article
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/15625368/
title
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.

Preserved source evidence · Not medical advice